SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R

被引：33

作者：

Sulkowski, M. S. ^{[1
]}

Bourliere, M. ^{[2
]}

Bronowicki, J. -P. ^{[3
]}

Streinu-Cercel, A. ^{[4
]}

Preotescu, L. ^{[4
]}

Asselah, T. ^{[5
]}

Pawlotsky, J. -M. ^{[6
]}

Shafran, S. ^{[7
]}

Pol, S. ^{[8
]}

Caruntu, F. A. ^{[4
]}

Mauss, S. ^{[9
]}

Larrey, D. ^{[10
]}

Haefner, C. ^{[11
]}

Datsenko, Y. ^{[11
]}

Stern, J. O. ^{[12
]}

Kubiak, R. ^{[11
]}

Boecher, W. ^{[11
]}

Steinmann, G. ^{[11
]}

机构：

[1] Johns Hopkins Univ, Baltimore, MD USA

[2] Hop St Joseph, Marseille, France

[3] Hop Brabois, Vandoeuvre Les Nancy, France

[4] Prof Dr Matei Bals Inst Infect Dis, Bucharest, Romania

[5] Hop Beaujon, Clichy, France

[6] Hop Henri Mondor, F-94010 Creteil, France

[7] Univ Alberta, Edmonton, AB, Canada

[8] Hop Cochin, F-75674 Paris, France

[9] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany

[10] Hop St Eloi, Montpellier, France

[11] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany

[12] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA

来源：

关键词：

D O I：

10.1016/S0168-8278(11)60068-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S30 / S30

页数：1